Clinical Trials
3 trialsNCT05085561 2025-08-06
SYCAMORE
Recursion Pharmaceuticals Inc.
Phase 2 Completed
NCT03474614 2024-04-19
Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation
St. Joseph's Hospital and Medical Center, Phoenix
Phase 2 Terminated
NCT03589014 2022-02-25
Treat_CCM
Mario Negri Institute for Pharmacological Research
Phase 2 Completed